Therapix Biosciences looks for new CEO
May 25, 2017Therapix Biosciences’s Chief Executive Officer Dr. Elran Haber will step down from his position to pursue other professional opportunities.
The company’s Board of Directors is undertaking a search to identify a permanent, U.S. based Chief Executive Officer. Dr. Haber will continue to serve in his position while the search for a new Chief Executive Officer takes place.
“On behalf of the Therapix Board of Directors, I would like to thank Dr. Haber for his extraordinary service to our Company. Therapix made considerable progress under his leadership, including a successful U.S. initial public offering, and significant advancement in the Company’s clinical development programs,” commented Dr. Ascher Shmulewitz, Chairman of the Board of Therapix.
